New Edge Advisors, LLC Evolus, Inc. Transaction History

New Edge Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$10.45 - $13.76 $6,155 - $8,104	-589 Reduced 85.49%	100 $1,000
Q1 2024 May 14, 2024	BUY	$9.99 - $14.91 $6,883 - $10,272	689 New	689 $9,000
Q4 2022 Feb 14, 2023	BUY	$6.52 - $8.95 $1,525 - $2,094	234 New	234 $1,000
Q2 2022 Aug 09, 2022	SELL	$10.22 - $13.94 $108,158 - $147,527	-10,583 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$5.22 - $11.78 $45,539 - $102,768	-8,724 Reduced 45.19%	10,583 $119,000
Q4 2021 Feb 17, 2022	SELL	$5.37 - $8.38 $6,358 - $9,921	-1,184 Reduced 5.78%	19,307 $126,000
Q3 2021 Oct 29, 2021	SELL	$7.36 - $13.67 $55,891 - $103,809	-7,594 Reduced 27.04%	20,491 $156,000
Q2 2021 Jul 22, 2021	SELL	$8.42 - $13.96 $20,991 - $34,802	-2,493 Reduced 8.15%	28,085 $355,000
Q1 2021 Apr 26, 2021	BUY	$3.2 - $16.51 $97,849 - $504,842	30,578 New	30,578 $397,000

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $611M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on New Edge Advisors, LLC with notifications on news.